SARS-CoV-2 Infection and Antibody Response in a Symptomatic Cat from Italy with Intestinal B-Cell Lymphoma

Since the coronavirus disease (COVID-19) pandemic was first identified in early 2020, rare cases of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in pet cats have been reported worldwide. Some reports of cats with SARS-CoV-2 showed self-limiting respiratory or gastrointestin...

Full description

Bibliographic Details
Main Authors: Julia Klaus, Carlo Palizzotto, Eric Zini, Marina L. Meli, Chiara Leo, Herman Egberink, Shan Zhao, Regina Hofmann-Lehmann
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/13/3/527
_version_ 1797540328119468032
author Julia Klaus
Carlo Palizzotto
Eric Zini
Marina L. Meli
Chiara Leo
Herman Egberink
Shan Zhao
Regina Hofmann-Lehmann
author_facet Julia Klaus
Carlo Palizzotto
Eric Zini
Marina L. Meli
Chiara Leo
Herman Egberink
Shan Zhao
Regina Hofmann-Lehmann
author_sort Julia Klaus
collection DOAJ
description Since the coronavirus disease (COVID-19) pandemic was first identified in early 2020, rare cases of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in pet cats have been reported worldwide. Some reports of cats with SARS-CoV-2 showed self-limiting respiratory or gastrointestinal disease after suspected human-to-feline transmission via close contact with humans with SARS-CoV-2. In the present study, we investigated a cat with SARS-CoV-2 that was presented to a private animal clinic in Northern Italy in May 2020 in a weak clinical condition due to an underlying intestinal B-cell lymphoma. The cat developed signs of respiratory tract disease, including a sneeze, a cough and ocular discharge, three days after an oropharyngeal swab tested positive for SARS-CoV-2 viral RNA using two real-time reverse transcriptase polymerase chain reaction (RT-qPCR) assays for the envelope (<i>E</i>) and RNA-dependent RNA polymerase (<i>RdRp</i>) gene. Thus, SARS-CoV-2 viral RNA was detectable prior to the onset of clinical signs. Five and six months after positive molecular results, the serological testing substantiated the presence of a SARS-CoV-2 infection in the cat with the detection of anti-SARS-CoV-2 receptor binding domain (RBD) immunoglobulin (IgG) antibodies and neutralizing activity in a surrogate virus neutralization assay (sVNT). To the best of our knowledge, this extends the known duration of seropositivity of SARS-CoV-2 in a cat. Our study provides further evidence that cats are susceptible to SARS-CoV-2 under natural conditions and strengthens the assumption that comorbidities may play a role in the development of clinical disease.
first_indexed 2024-03-10T12:59:30Z
format Article
id doaj.art-f05e59070b4c407894f08e09f556e458
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-10T12:59:30Z
publishDate 2021-03-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-f05e59070b4c407894f08e09f556e4582023-11-21T11:40:11ZengMDPI AGViruses1999-49152021-03-0113352710.3390/v13030527SARS-CoV-2 Infection and Antibody Response in a Symptomatic Cat from Italy with Intestinal B-Cell LymphomaJulia Klaus0Carlo Palizzotto1Eric Zini2Marina L. Meli3Chiara Leo4Herman Egberink5Shan Zhao6Regina Hofmann-Lehmann7Clinical Laboratory, Department of Clinical Diagnostics and Services, and Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, 8057 Zurich, SwitzerlandAniCura Istituto Veterinario Novara, Strada Provinciale 9, 28060 Granozzo con Monticello, Novara, ItalyAniCura Istituto Veterinario Novara, Strada Provinciale 9, 28060 Granozzo con Monticello, Novara, ItalyClinical Laboratory, Department of Clinical Diagnostics and Services, and Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, 8057 Zurich, SwitzerlandAniCura Istituto Veterinario Novara, Strada Provinciale 9, 28060 Granozzo con Monticello, Novara, ItalyDepartment of Biomolecular Health Sciences, Faculty of Veterinary Medicine, University of Utrecht, 3584 CL Utrecht, The NetherlandsDepartment of Biomolecular Health Sciences, Faculty of Veterinary Medicine, University of Utrecht, 3584 CL Utrecht, The NetherlandsClinical Laboratory, Department of Clinical Diagnostics and Services, and Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, 8057 Zurich, SwitzerlandSince the coronavirus disease (COVID-19) pandemic was first identified in early 2020, rare cases of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in pet cats have been reported worldwide. Some reports of cats with SARS-CoV-2 showed self-limiting respiratory or gastrointestinal disease after suspected human-to-feline transmission via close contact with humans with SARS-CoV-2. In the present study, we investigated a cat with SARS-CoV-2 that was presented to a private animal clinic in Northern Italy in May 2020 in a weak clinical condition due to an underlying intestinal B-cell lymphoma. The cat developed signs of respiratory tract disease, including a sneeze, a cough and ocular discharge, three days after an oropharyngeal swab tested positive for SARS-CoV-2 viral RNA using two real-time reverse transcriptase polymerase chain reaction (RT-qPCR) assays for the envelope (<i>E</i>) and RNA-dependent RNA polymerase (<i>RdRp</i>) gene. Thus, SARS-CoV-2 viral RNA was detectable prior to the onset of clinical signs. Five and six months after positive molecular results, the serological testing substantiated the presence of a SARS-CoV-2 infection in the cat with the detection of anti-SARS-CoV-2 receptor binding domain (RBD) immunoglobulin (IgG) antibodies and neutralizing activity in a surrogate virus neutralization assay (sVNT). To the best of our knowledge, this extends the known duration of seropositivity of SARS-CoV-2 in a cat. Our study provides further evidence that cats are susceptible to SARS-CoV-2 under natural conditions and strengthens the assumption that comorbidities may play a role in the development of clinical disease.https://www.mdpi.com/1999-4915/13/3/527SARS-CoV-2domestic catRT-qPCRcomorbiditycompanion animalB-cell lymphoma
spellingShingle Julia Klaus
Carlo Palizzotto
Eric Zini
Marina L. Meli
Chiara Leo
Herman Egberink
Shan Zhao
Regina Hofmann-Lehmann
SARS-CoV-2 Infection and Antibody Response in a Symptomatic Cat from Italy with Intestinal B-Cell Lymphoma
Viruses
SARS-CoV-2
domestic cat
RT-qPCR
comorbidity
companion animal
B-cell lymphoma
title SARS-CoV-2 Infection and Antibody Response in a Symptomatic Cat from Italy with Intestinal B-Cell Lymphoma
title_full SARS-CoV-2 Infection and Antibody Response in a Symptomatic Cat from Italy with Intestinal B-Cell Lymphoma
title_fullStr SARS-CoV-2 Infection and Antibody Response in a Symptomatic Cat from Italy with Intestinal B-Cell Lymphoma
title_full_unstemmed SARS-CoV-2 Infection and Antibody Response in a Symptomatic Cat from Italy with Intestinal B-Cell Lymphoma
title_short SARS-CoV-2 Infection and Antibody Response in a Symptomatic Cat from Italy with Intestinal B-Cell Lymphoma
title_sort sars cov 2 infection and antibody response in a symptomatic cat from italy with intestinal b cell lymphoma
topic SARS-CoV-2
domestic cat
RT-qPCR
comorbidity
companion animal
B-cell lymphoma
url https://www.mdpi.com/1999-4915/13/3/527
work_keys_str_mv AT juliaklaus sarscov2infectionandantibodyresponseinasymptomaticcatfromitalywithintestinalbcelllymphoma
AT carlopalizzotto sarscov2infectionandantibodyresponseinasymptomaticcatfromitalywithintestinalbcelllymphoma
AT ericzini sarscov2infectionandantibodyresponseinasymptomaticcatfromitalywithintestinalbcelllymphoma
AT marinalmeli sarscov2infectionandantibodyresponseinasymptomaticcatfromitalywithintestinalbcelllymphoma
AT chiaraleo sarscov2infectionandantibodyresponseinasymptomaticcatfromitalywithintestinalbcelllymphoma
AT hermanegberink sarscov2infectionandantibodyresponseinasymptomaticcatfromitalywithintestinalbcelllymphoma
AT shanzhao sarscov2infectionandantibodyresponseinasymptomaticcatfromitalywithintestinalbcelllymphoma
AT reginahofmannlehmann sarscov2infectionandantibodyresponseinasymptomaticcatfromitalywithintestinalbcelllymphoma